Weight Loss Injections and Gallbladder Issues: What You Should Know

Why do weight loss injections affect the gallbladder?

Two separate mechanisms are at work. First, GLP-1 medicines slow gastric emptying, which also reduces the signal for the gallbladder to contract after meals. A gallbladder that empties less frequently allows bile to become more concentrated, and thickened bile is one of the main conditions that allow cholesterol crystals to form into stones.

Second, losing weight quickly, regardless of how you achieve it, shifts the chemical balance of bile. Fat mobilised during a calorie deficit raises the amount of cholesterol secreted into bile faster than the body can balance it with bile salts. That is not unique to GLP-1 medicines (it is seen after bariatric surgery and with very-low-calorie diets too) but the weight loss on Mounjaro or Wegovy can be substantial, so the background risk rises accordingly.

The NHS patient information for tirzepatide lists gallbladder problems as a known side effect, and the same appears in the NHS's semaglutide information page. If you want a fuller picture of how weight loss injections and the gallbladder are connected, our dedicated page covers the relationship in more depth. Knowing the mechanism matters because it explains why symptoms can appear weeks or months into treatment, not just at the start, and why the risk does not simply disappear by taking a lower dose.

What symptoms should prompt urgent medical attention?

Most people on GLP-1 treatment never develop a gallbladder problem they notice. But when they do, the symptoms can range from mild discomfort to a medical emergency, and telling the two apart quickly is important.

Seek same-day medical help if you develop severe pain in the upper right side of your abdomen or the centre of your stomach that radiates to your right shoulder or back, especially if it comes on suddenly after eating. A high temperature alongside this pain raises the possibility of cholecystitis (gallbladder inflammation), which can become serious within hours. Yellowing of the skin or the whites of the eyes suggests bile duct involvement and needs urgent assessment.

Milder, intermittent right-sided aching after fatty meals may be biliary colic from a smaller stone passing through a duct — still worth reporting to your prescriber or GP promptly, even if it passes. Do not wait for a routine appointment. If you have already had your gallbladder removed, different anatomy means symptoms may present differently; our separate page on weight loss injections after gallbladder removal covers what changes in that situation.

If you suspect a side effect is connected to your treatment, you can also report it directly to the MHRA through the Yellow Card scheme. Patient reports help regulators track emerging safety signals across the population.

Does having a history of gallstones rule out treatment?

Not automatically. A past episode of gallstones, or even previous cholecystectomy (surgical removal of the gallbladder), does not appear on a blanket contraindication list for tirzepatide or semaglutide. What it does is add clinical weight to the conversation. A prescriber assessing your suitability will want to know whether you had complications, how long ago it was, whether you still have your gallbladder, and what your current liver and biliary health looks like.

People who have had their gallbladder removed can still develop bile duct stones or biliary symptoms, so the absence of a gallbladder is not a clean slate. Our page on using weight loss injections without a gallbladder goes into more detail on that specific situation.

For those with an intact gallbladder and a relevant history, some prescribers discuss proactive monitoring, such as periodic ultrasound, though this is a clinical judgement call rather than a protocol requirement. The right answer depends on your individual picture, which is exactly the kind of thing our clinical team works through during the consultation.

Can the risk be reduced, and does it affect which injection suits you?

There is no way to eliminate the gallbladder risk entirely while on an effective GLP-1 medicine, but a few practical factors may help keep it lower. Avoiding very rapid calorie restriction on top of the appetite suppression the medicine already produces is worth discussing with your prescriber. Staying well hydrated supports normal bile flow. Regular physical activity, which is recommended alongside both Mounjaro and Wegovy regardless of gallbladder concerns, also supports healthy bile cycling.

As for which injection carries more risk, the evidence does not clearly favour one over the other at this point. Both tirzepatide (Mounjaro) and semaglutide (Wegovy) show elevated gallbladder event rates compared to placebo in large trials, and the relationship appears linked to the degree of weight loss rather than to either drug's specific pharmacology. If you want a broader overview of how these two medicines compare across multiple dimensions, the weight loss injections overview is a useful starting point.

One simple checking habit that takes less than a minute: after eating a fatty meal, note whether you feel any aching under your right ribs or between your shoulder blades. Not every flutter is significant, but a pattern that repeats is worth mentioning to your prescriber sooner rather than later. Our page on whether weight loss injections can cause gallbladder problems explains the evidence behind that question in more detail, and our page on weight loss injections with no gall bladder is worth reading if you have already had yours removed. Our prescribers discuss suitability and individual risk factors, including gallbladder history, as a standard part of the consultation, check your eligibility to start that conversation.